Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


Published ahead of print on September 13, 2006
J Am Soc Nephrol 17: 2664-2669, 2006
© 2006 American Society of Nephrology
doi: 10.1681/ASN.2006070798

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ASN.2006070798v1
17/10/2664    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhao, H. J.
Right arrow Articles by Harris, R. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhao, H. J.
Right arrow Articles by Harris, R. C.

Fast Track

Endothelial Nitric Oxide Synthase Deficiency Produces Accelerated Nephropathy in Diabetic Mice

Hui John Zhao*, Suwan Wang*, Huifang Cheng*, Ming-zhi Zhang*, Takamune Takahashi*, Agnes B. Fogo*,{dagger}, Matthew D. Breyer* and Raymond C. Harris*

* Division of Nephrology and Hypertension, Department of Medicine, and {dagger} Department of Pathology, Vanderbilt University, Nashville, Tennessee

Address correspondence to: Dr. Raymond C. Harris, Department of Medicine, Division of Nephrology and Hypertension, Vanderbilt University Medical Center, C-3121 MCN, Nashville, TN 37232. Phone: 615-343-0030; Fax: 615-343-2675; E-mail: ray.harris{at}vanderbilt.edu

Functionally significant polymorphisms in endothelial nitric oxide synthase (eNOS) and reduced vascular eNOS activity have been associated with increased human diabetic nephropathy (DN), but the pathogenic role of eNOS deficiency in the development of DN has not yet been confirmed. This study characterizes the severity of DN in eNOS–/– mice that were backcrossed to C57BLKS/J db/db mice. Although the severity of hyperglycemia was similar to C57BLKS/J db/db mice, by 26 wk, eNOS–/– C57BLKS/J db/db mice exhibited dramatic albuminuria, arteriolar hyalinosis, increased glomerular basement membrane thickness, mesangial expansion, mesangiolysis, and focal segmental and early nodular glomerulosclerosis. Even more remarkable, eNOS–/– C57BLKS db/db exhibited decreases in GFR to levels <50% of that in eNOS+/+ C57BLKS db/db, as confirmed by increased serum creatinine. In summary, eNOS–/– db/db mice provide the most robust model of type II DN that has been described to date and support a role for deficient eNOS-derived NO production in the pathogenesis of DN.




This article has been cited by other articles:


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
P. Balakumar, Vishal Arvind Chakkarwar, V. Kumar, A. Jain, J. Reddy, and M. Singh
Experimental models for nephropathy
Journal of Renin-Angiotensin-Aldosterone System, December 1, 2008; 9(4): 189 - 195.
[Abstract] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
S. Park, B. J. Bivona, Y. Feng, E. Lazartigues, and L. M. Harrison-Bernard
Intact renal afferent arteriolar autoregulatory responsiveness in db/db mice
Am J Physiol Renal Physiol, November 1, 2008; 295(5): F1504 - F1511.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
M. D. Breyer
Stacking the Deck for Drug Discovery in Diabetic Nephropathy: In Search of an Animal Model
J. Am. Soc. Nephrol., September 1, 2008; 19(9): 1623 - 1624.
[Full Text] [PDF]


Home page
HypertensionHome page
M. W. Brands and H. Labazi
Role of Glomerular Filtration Rate in Controlling Blood Pressure Early in Diabetes
Hypertension, August 1, 2008; 52(2): 188 - 194.
[Full Text] [PDF]


Home page
DiabetesHome page
Y. Qian, E. Feldman, S. Pennathur, M. Kretzler, and F. C. Brosius III
From Fibrosis to Sclerosis: Mechanisms of Glomerulosclerosis in Diabetic Nephropathy
Diabetes, June 1, 2008; 57(6): 1439 - 1445.
[Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
R. Faulhaber-Walter, L. Chen, M. Oppermann, S. M. Kim, Y. Huang, N. Hiramatsu, D. Mizel, H. Kajiyama, P. Zerfas, J. P. Briggs, et al.
Lack of A1 Adenosine Receptors Augments Diabetic Hyperfiltration and Glomerular Injury
J. Am. Soc. Nephrol., April 1, 2008; 19(4): 722 - 730.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
K. J. Williams, G. Qiu, H. K. Usui, S. R. Dunn, P. McCue, E. Bottinger, R. V. Iozzo, and K. Sharma
Decorin Deficiency Enhances Progressive Nephropathy in Diabetic Mice
Am. J. Pathol., November 1, 2007; 171(5): 1441 - 1450.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
T. Nakagawa, M. Segal, B. Croker, and R. J. Johnson
A breakthrough in diabetic nephropathy: the role of endothelial dysfunction
Nephrol. Dial. Transplant., October 1, 2007; 22(10): 2775 - 2777.
[Full Text] [PDF]


Home page
Am. J. Pathol.Home page
Y. Kanetsuna, K. Takahashi, M. Nagata, M. A. Gannon, M. D. Breyer, R. C. Harris, and T. Takahashi
Deficiency of Endothelial Nitric-Oxide Synthase Confers Susceptibility to Diabetic Nephropathy in Nephropathy-Resistant Inbred Mice
Am. J. Pathol., May 1, 2007; 170(5): 1473 - 1484.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
S. E. Quaggin and T. M. Coffman
Toward a Mouse Model of Diabetic Nephropathy: Is Endothelial Nitric Oxide Synthase the Missing Link?
J. Am. Soc. Nephrol., February 1, 2007; 18(2): 364 - 366.
[Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP